News Articles Tagged: Computational Drug Design

Computational Insights into Mometasone Furoate Binding to FXR: Guiding Future Drug Design

Explore the computational modeling and simulation studies that shed light on how Mometasone Furoate binds to the FXR receptor, offering critical data for future pharmaceutical design.

Chemical Synthesis Meets Alzheimer's Therapy: NINGBO INNO PHARMCHEM CO.,LTD.'s 2-Aminopyridine Innovations

NINGBO INNO PHARMCHEM CO.,LTD. is advancing Alzheimer's disease treatment with the synthesis of novel 2-aminopyridine derivatives, potent cholinesterase inhibitors, validated by computational studies.

The Future of Pharmaceutical Innovation: Future Research Directions for 2-Amino-5-hydroxypyrimidine

NINGBO INNO PHARMCHEM CO.,LTD. explores the promising future research directions for 2-Amino-5-hydroxypyrimidine (CAS 143489-45-6), focusing on novel synthetic methodologies, undiscovered biological activities, and advanced drug design strategies.

Exploring the Computational Insights and Biological Applications of 1,4-Diacetylbenzene Derivatives

Delve into the computational studies and diverse biological activities of 1,4-Diacetylbenzene derivatives, uncovering their potential in drug design and understanding molecular interactions.

Exploring the Chemical Frontier: Designing Novel P-Coumaric Acid Analogs for Neuroprotection

Discover how computational chemistry is being used to design new P-Coumaric Acid derivatives with enhanced neuroprotective and antioxidant capabilities for treating neurological disorders.